The KCNA2 & Rare Epilepsy’s Podcast

How Genomics Can Inform Medication Decisions in Rare Epilepsies with Drs. Gray & Musarra - Part 2

33 min · 28. maj 2026
episode How Genomics Can Inform Medication Decisions in Rare Epilepsies with Drs. Gray & Musarra - Part 2 cover

Description

In Part 2 of this series of the KCNA2 & Rare Epilepsy Podcast, Dr. Nancy Musarra continues her conversation with Dr. Erika Gray, pharmacist and Chief Medical Officer of Toolbox Genomics, to explore how pharmacogenomics and genomics may help families make more informed treatment decisions. This episode focuses on how the body processes anti-seizure medications, why some people break down medications too quickly or too slowly, how side effects and adverse drug reactions may happen, and how genomic insights may help guide conversations with doctors. Dr. Gray also explains how genomics can offer insight into sleep, histamine responses, nutrition, and other factors that may affect children and adults living with rare epilepsy and neurological conditions. If you are a parent, caregiver, clinician, or someone living with a rare epilepsy, this episode offers practical and accessible information about using genomics to better understand the whole person, not just the diagnosis. Learn more: Toolbox Genomics: https://www.toolboxgenomics.com/ [https://www.toolboxgenomics.com/] KCNA2 Epilepsy Foundation: https://www.kcna2epilepsy.org/ [https://www.kcna2epilepsy.org/]

Comments

0

Be the first to comment

Sign up now and become a member of the The KCNA2 & Rare Epilepsy’s Podcast community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

16 episodes

episode Living With KCNA2 Epilepsy: One Father’s Story of Seizures, Strength & Hope with Jeffrey Gomez artwork

Living With KCNA2 Epilepsy: One Father’s Story of Seizures, Strength & Hope with Jeffrey Gomez

In this episode of the KCNA2 & Rare Epilepsy Podcast, Dr. Nancy Musarra sits down with Jeffrey Gomez to talk about his daughter’s journey with KCNA2-related rare epilepsy. Jeffrey shares how his daughter’s seizures began just before her first birthday, changing what should have been a joyful family celebration into the beginning of a long and frightening medical journey. He talks about the early hospital visits, the uncertainty around her symptoms, the emotional stress of emergency testing, and the heartbreak of watching seizures continue without control. He also reflects on how hard it was to search for answers while navigating care, learning unfamiliar medical language, and trying to understand what was happening to his child. Dr. Musarra and Jeffrey also discuss the long road to genetic testing and diagnosis. Jeffrey explains how years passed before more advanced sequencing revealed a change in the KCNA2 gene. Their conversation highlights how confusing genetic results can feel for families and why support from rare disease communities can make such a difference. The episode also explores daily life beyond the diagnosis. Jeffrey shares how his daughter experienced delays in speech, language, and motor development, and how his family used pictograms, sign language, flashcards, and other visual supports to help her communicate. He also talks about the challenges and progress of raising a bilingual child with communication delays, offering hope to families who are still waiting for language to emerge. Jeffrey speaks openly about school, autism, mobility challenges, safety concerns, and the need for meaningful support both at home and in the classroom. He offers an honest perspective as a parent who has learned through experience how important it is to ask questions, connect with other families, and keep looking for resources that truly help. His message is clear. Community matters, shared knowledge matters, and no family should have to figure this out alone. This is a heartfelt and encouraging conversation about what it really means to live with rare epilepsy. It speaks to the emotional, developmental, and practical realities families face, while also holding onto hope for better treatments, stronger support, and future breakthroughs such as gene therapy. Whether you are a parent, caregiver, family member, clinician, researcher, or someone newly navigating a KCNA2 diagnosis, this episode offers insight, connection, and encouragement. Learn more about KCNA2 on the foundation's website: https://www.kcna2epilepsy.org/ [https://www.kcna2epilepsy.org/] #KCNA2 #RareEpilepsy #EpilepsyAwareness #RareDisease #GeneticEpilepsy #KCNA2Community #CaregiverSupport #SpecialNeedsParenting #RareDiseaseAwareness #HopeForACure

Yesterday44 min
episode Genetic Testing in Rare Epilepsy: What Families Need to Know with Gillian Prinzing & Nancy Musarra artwork

Genetic Testing in Rare Epilepsy: What Families Need to Know with Gillian Prinzing & Nancy Musarra

In this episode of the KCNA2 & Rare Epilepsy Podcast, Dr. Nancy Msara speaks with licensed genetic counselor Gillian Prinzing from Boston Children’s Hospital about genetic testing in epilepsy. They talk through what genetic testing is, why it may be recommended, the different types of testing families may hear about, and what results like a diagnosis or a variant of uncertain significance (VUS) can mean in real life. They also discuss retesting, reanalysis, family testing, and why genetic results are meant to inform care, not define a person. This episode is for families looking for answers, caregivers trying to better understand the process, and anyone navigating rare epilepsy and genetic diagnosis. In this episode, we cover: * What genetic testing is * Why genetic testing is ordered in epilepsy * Genome sequencing vs. exome sequencing vs. panels * Reanalysis of older genetic results * What a VUS result means * Whether parents and siblings should be tested * When genetic testing may be helpful * Hope for the future of rare epilepsy diagnosis and care Listen, follow, and share to help more families find support, information, and connection: https://www.kcna2epilepsy.org/ [https://www.kcna2epilepsy.org/]

4. juni 202631 min
episode How Genomics Can Inform Medication Decisions in Rare Epilepsies with Drs. Gray & Musarra - Part 2 artwork

How Genomics Can Inform Medication Decisions in Rare Epilepsies with Drs. Gray & Musarra - Part 2

In Part 2 of this series of the KCNA2 & Rare Epilepsy Podcast, Dr. Nancy Musarra continues her conversation with Dr. Erika Gray, pharmacist and Chief Medical Officer of Toolbox Genomics, to explore how pharmacogenomics and genomics may help families make more informed treatment decisions. This episode focuses on how the body processes anti-seizure medications, why some people break down medications too quickly or too slowly, how side effects and adverse drug reactions may happen, and how genomic insights may help guide conversations with doctors. Dr. Gray also explains how genomics can offer insight into sleep, histamine responses, nutrition, and other factors that may affect children and adults living with rare epilepsy and neurological conditions. If you are a parent, caregiver, clinician, or someone living with a rare epilepsy, this episode offers practical and accessible information about using genomics to better understand the whole person, not just the diagnosis. Learn more: Toolbox Genomics: https://www.toolboxgenomics.com/ [https://www.toolboxgenomics.com/] KCNA2 Epilepsy Foundation: https://www.kcna2epilepsy.org/ [https://www.kcna2epilepsy.org/]

28. maj 202633 min
episode Epilepsy & Mental Health Are More Connected Than People Realize with Monica Lopez Morales artwork

Epilepsy & Mental Health Are More Connected Than People Realize with Monica Lopez Morales

In this episode of the KCNA2 & Rare Epilepsy Podcast, Monica Lopez Morales returns for a powerful and deeply honest conversation about the connection between epilepsy and mental health. Drawing from more than four decades of lived experience, Monica shares how epilepsy can affect far more than seizures alone, touching anxiety, depression, PTSD, stigma, isolation, and the daily emotional weight that many people carry silently. Together, Monica and Nancy talk about what seizures are in simple terms, how epilepsy and mental health are deeply intertwined, and why emotional wellness should be part of epilepsy care from the very beginning. Monica also speaks candidly about support groups, self-advocacy, safe disclosure, movement, nutrition, and recognizing when help is needed. This episode is especially valuable for adults living with epilepsy, parents raising children with epilepsy, family members, caregivers, and clinicians. It is also an important reminder that epilepsy affects the whole family, and that mental health symptoms may impact parents, siblings, and caregivers too. Monica encourages families to create safe spaces for children and teens to talk openly, and she reminds listeners that no one should have to carry this alone. And remember... This episode is for educational and informational purposes only and is not medical advice. It also includes discussion of depression, suicidal ideation, and mental health challenges related to epilepsy. Please speak with your doctor or epilepsy care team about diagnosis, treatment, medications, seizure safety, and mental health support. About KCNA2 KCNA2-related epilepsy is a rare neurological condition that affects how the brain sends electrical signals, often leading to seizures, movement challenges, and developmental differences. Every experience is unique, but community and shared stories play a critical role in support and understanding. You can read more on our website https://www.kcna2epilepsy.org/

21. maj 202634 min
episode Rare Epilepsy and Genomic Testing Explained with Dr. Erika Gray and Dr. Nancy Musarra artwork

Rare Epilepsy and Genomic Testing Explained with Dr. Erika Gray and Dr. Nancy Musarra

In this episode of the KCNA2 & Rare Epilepsy Podcast, Nancy sits down with Dr. Erika Gray, pharmacist and Chief Medical Officer of Toolbox Genomics, to break down the difference between genetics and genomics in a way families can actually understand. Together, they talk about how gene variants like KCNA2 can affect potassium channels, why gain-of-function and loss-of-function matter, how genomic testing may help guide treatment decisions, and what families should know about privacy, insurance, and next steps in testing. This is Part 1 of a two-part conversation focused on making a complex topic more clear, practical, and hopeful for families navigating rare epilepsy. Whether you are a parent, caregiver, clinician, or researcher, this episode offers an accessible introduction to how genomics may support more personalized care for children with rare epilepsies and other neurological conditions. Learn more: Toolbox Genomics: https://www.toolboxgenomics.com/ [https://www.toolboxgenomics.com/] KCNA2 Epilepsy Foundation: https://www.kcna2epilepsy.org/ [https://www.kcna2epilepsy.org/]

14. maj 202639 min